MBAV:NASDAQM3-Brigade Acquisition V Corp. Analysis
Data as of 2026-05-19 - not real-time
$10.81
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at $10.805, just above a key support level of $10.72 and below a resistance of $10.89, with the 20‑day SMA (10.805) sitting above the 50‑day (10.785) and 200‑day (10.655) averages, indicating a short‑term bullish alignment. RSI sits near 50, suggesting neutral momentum, while the MACD histogram is slightly negative and the signal line is bearish, hinting at potential short‑term weakness. Volume is trending upward despite today’s low absolute volume, and the beta of ~0.06 combined with a 30‑day volatility of 3.85% points to very low market‑wide price sensitivity. Fundamentally, the company reports zero revenue, a negative book value per share of –$0.54, and an astronomically high trailing P/E of 83 versus an industry average of 16, signaling severe overvaluation. The DCF‑derived fair value of $0.014 is a fraction of the current price, and the max drawdown of –22% underscores the downside risk already realized. The “Extreme Greed” reading on the Fear & Greed Index reflects market optimism that may be disconnected from the underlying financial reality. Overall, the technicals show modest bullish bias, but the fundamentals are profoundly weak, making the stock a high‑risk speculative play.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near technical support with bullish SMA crossover
- Bearish MACD signal may limit upside
- Low beta and volatility reduce market‑wide risk
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Potential value creation from a future merger or acquisition
- Increasing volume suggests growing investor interest
- Current price still above support, offering limited downside
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- No operating business and negative book value
- Extreme overvaluation relative to DCF fair value
- High sector and regulatory risk for shell companies
Key Metrics & Analysis
Financial Health
P/E Ratio83.1
ROA-1.34%
P/B Ratio-20.0
Op. Cash Flow$-1465482
Free Cash Flow$142.3K
Industry P/E16.7
Technical Analysis
TrendBullish
RSI50.3
Support$10.72
Resistance$10.89
MA 20$10.81
MA 50$10.78
MA 200$10.66
MACDBearish
VolumeIncreasing
Fear & Greed Index89.25
Valuation
Fair Value$0.01
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.06
Volatility3.85%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.